Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore.
Department of Neurology, National Neuroscience Institute, Singapore, Singapore; Duke-National University of Singapore Medical School, Singapore, Singapore.
Neurobiol Aging. 2019 Feb;74:235.e1-235.e4. doi: 10.1016/j.neurobiolaging.2018.09.013. Epub 2018 Sep 21.
Recent whole-exome sequencing studies in European patients with Parkinson's disease (PD) have identified potential risk variants across 33 novel PD candidate genes. We aim to determine if these reported candidate genes are similarly implicated in Asians by assessing common, rare, and novel nonsynonymous coding variants by sequencing all 33 genes in 198 Chinese samples and genotyping coding variants in an independent set of 9756 Chinese samples. We carried out further targeted sequencing of CD36 in an additional 576 Chinese and Korean samples. We found that only 8 of 43 reported risk variants were polymorphic in our Chinese samples. We identified several heterozygotes for rare loss-of-function mutations, including the reported CD36 p.Gln74Ter variant, in both cases and controls. We also observed 2 potential compound heterozygotes among PD cases for rare loss-of-function mutations in CD36 and SSPO. The other reported variants were common in East Asians and not associated with PD, completely absent, or only found in controls. Therefore, the 33 reported candidate genes and associated variants are unlikely to confer significant PD risk in the East Asian population.
最近对欧洲帕金森病 (PD) 患者的全外显子组测序研究在 33 个新的 PD 候选基因中发现了潜在的风险变异体。我们旨在通过对 198 个中国样本中的所有 33 个基因进行测序和对 9756 个中国样本中的编码变异进行基因分型,来确定这些报告的候选基因是否同样与亚洲人有关。我们还对另外 576 个中国和韩国样本中的 CD36 进行了进一步的靶向测序。我们发现,在我们的中国样本中,只有 43 个报告的风险变异中有 8 个是多态性的。我们在病例和对照中都发现了几个罕见的失功能突变的杂合子,包括报告的 CD36 p.Gln74Ter 变异体。我们还在 PD 病例中观察到了 2 个潜在的复合杂合子,这些病例中的 CD36 和 SSPO 存在罕见的失功能突变。其他报告的变异体在东亚人中很常见,与 PD 无关,完全缺失,或只在对照中发现。因此,这 33 个报告的候选基因和相关变异体不太可能在东亚人群中赋予 PD 显著风险。